AULS.F Stock Overview
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Austar Lifesciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.10 |
| 52 Week High | HK$2.10 |
| 52 Week Low | HK$0.0007 |
| Beta | 1.07 |
| 1 Month Change | 0% |
| 3 Month Change | -61.54% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| AULS.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | 0.1% | 1.6% |
| 1Y | n/a | 2.8% | 25.1% |
Return vs Industry: Insufficient data to determine how AULS.F performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how AULS.F performed against the US Market.
Price Volatility
| AULS.F volatility | |
|---|---|
| AULS.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AULS.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AULS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 1,610 | Mars Ho | www.austar.com.hk |
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; clean room enclosure, automation control and monitoring systems; and freeze-dryer, sterile filling, and visual inspection equipment, as well as clean utility, powder, and solid equipment and systems.
Austar Lifesciences Limited Fundamentals Summary
| AULS.F fundamental statistics | |
|---|---|
| Market cap | US$46.53m |
| Earnings (TTM) | -US$4.52m |
| Revenue (TTM) | US$244.39m |
0.2x
P/S Ratio-10.3x
P/E RatioIs AULS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AULS.F income statement (TTM) | |
|---|---|
| Revenue | CN¥1.76b |
| Cost of Revenue | CN¥1.43b |
| Gross Profit | CN¥336.05m |
| Other Expenses | CN¥368.66m |
| Earnings | -CN¥32.61m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.064 |
| Gross Margin | 19.05% |
| Net Profit Margin | -1.85% |
| Debt/Equity Ratio | 55.5% |
How did AULS.F perform over the long term?
See historical performance and comparison